In fact, we found that mutations in STAG2, SRSF2 and RUNX1 are independent prognostic factors, enough to define the course of the disease in terms of overall survival and leukemic transformation in isolated +8 MDS. The gene discussed is STAG2; the disease is myelodysplastic syndrome.